New cancer drug karonudib tested in humans for first time
Disease control
Completed
This early-phase trial tested a new drug, Karonudib, in 63 people with advanced solid tumors that had not responded to other treatments. The main goal was to find a safe dose and check for side effects. Researchers also looked for early signs that the drug might shrink tumors.
Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC